APA

Tsai D. E., Luger S. M., Andreadis C., Vogl D. T., Kemner A., Potuzak M., Goradia A., Loren A. W., Perl A. E., Schuster S. J., Porter D. L., Stadtmauer E. A., Goldstein S. C., Thompson J. E., Swider C., Bagg A., Mato A. R. & Carroll M. (20081003). A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Tsai Donald E, Luger Selina M, Andreadis Charalambos, Vogl Dan T, Kemner Allison, Potuzak Melissa, Goradia Ami, Loren Alison W, Perl Alexander E, Schuster Stephen J, Porter David L, Stadtmauer Edward A, Goldstein Steven C, Thompson James E, Swider Cezary, Bagg Adam, Mato Anthony R and Carroll Martin. 20081003. A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Tsai D. E., Luger S. M., Andreadis C., Vogl D. T., Kemner A., Potuzak M., Goradia A., Loren A. W., Perl A. E., Schuster S. J., Porter D. L., Stadtmauer E. A., Goldstein S. C., Thompson J. E., Swider C., Bagg A., Mato A. R. and Carroll M. (20081003). A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Tsai Donald E, Luger Selina M, Andreadis Charalambos, Vogl Dan T, Kemner Allison, Potuzak Melissa, Goradia Ami, Loren Alison W, Perl Alexander E, Schuster Stephen J, Porter David L, Stadtmauer Edward A, Goldstein Steven C, Thompson James E, Swider Cezary, Bagg Adam, Mato Anthony R and Carroll Martin. A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20081003.